The changing landscape of AML
Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany
20 Jun 2019
CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL
Dr Othman Al-Sawaf - Univesity of Cologne, Cologne, Germany
20 Jun 2019
Lymphodepleting chemotherapy in order to safely improve the expansion of HER2-CA...
Prof Shoba Navai - Baylor College of Medicine, Houston, USA
15 Apr 2019
New developments in soft tissue and bone sarcoma research
Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands
21 Mar 2019
Patient treatment preferences in relapsed/refractory multiple myeloma
Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos
3 Dec 2018
The international myeloma working group frailty score for elderly patients with ...
Ms Claudia Stege - Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
22 Nov 2018
Osteoporosis and osteopenia in elderly patients
Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland
22 Nov 2018
Treating myelodysplastic syndromes
Prof Hugo Fernandez - Moffitt Cancer Center, Tampa, USA
7 Aug 2018
Four studies about relapsed myeloma and advanced disease
Prof Melissa Alsina -Moffitt Cancer Center, Tampa, USA
7 Aug 2018
항암화학요법으로 인한 호중구감소증과 G-CSF의 역할
마티 아프로 교수 - 제놀리어 암 센터, 스위스 제놀리어
18 Jul 2018
Precision CAR T cell therapeutics
Prof Carl H. June - Perelman School of Medicine, Philadelphia, USA
6 Jul 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
4 Jul 2018
